446 related articles for article (PubMed ID: 19492870)
1. Developmental pharmacokinetics of gentamicin in preterm and term neonates: population modelling of a prospective study.
Nielsen EI; Sandström M; Honoré PH; Ewald U; Friberg LE
Clin Pharmacokinet; 2009; 48(4):253-63. PubMed ID: 19492870
[TBL] [Abstract][Full Text] [Related]
2. Population pharmacokinetics of gentamicin in premature newborns.
García B; Barcia E; Pérez F; Molina IT
J Antimicrob Chemother; 2006 Aug; 58(2):372-9. PubMed ID: 16782742
[TBL] [Abstract][Full Text] [Related]
3. Population pharmacokinetic study of gentamicin in a large cohort of premature and term neonates.
Fuchs A; Guidi M; Giannoni E; Werner D; Buclin T; Widmer N; Csajka C
Br J Clin Pharmacol; 2014 Nov; 78(5):1090-101. PubMed ID: 24938850
[TBL] [Abstract][Full Text] [Related]
4. Gentamicin pharmacokinetics and dosing in neonates with hypoxic ischemic encephalopathy receiving hypothermia.
Frymoyer A; Meng L; Bonifacio SL; Verotta D; Guglielmo BJ
Pharmacotherapy; 2013 Jul; 33(7):718-26. PubMed ID: 23553582
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of vancomycin dosing regimens in preterm and term neonates using Monte Carlo simulations.
Mehrotra N; Tang L; Phelps SJ; Meibohm B
Pharmacotherapy; 2012 May; 32(5):408-19. PubMed ID: 22488303
[TBL] [Abstract][Full Text] [Related]
6. Extended-interval Dosing of Gentamicin in Premature Neonates Born at <32 Weeks' Gestation and >7 Days of age.
Sundaram A; Alshaikh B; Dersch-Mills D; Dobry J; Akierman AR; Yusuf K
Clin Ther; 2017 Jun; 39(6):1233-1241. PubMed ID: 28579209
[TBL] [Abstract][Full Text] [Related]
7. Vancomycin pharmacokinetics in preterm neonates and the prediction of adult clearance.
Anderson BJ; Allegaert K; Van den Anker JN; Cossey V; Holford NH
Br J Clin Pharmacol; 2007 Jan; 63(1):75-84. PubMed ID: 16869817
[TBL] [Abstract][Full Text] [Related]
8. External Validation of Model-Based Dosing Guidelines for Vancomycin, Gentamicin, and Tobramycin in Critically Ill Neonates and Children: A Pragmatic Two-Center Study.
Hartman SJF; Orriëns LB; Zwaag SM; Poel T; de Hoop M; de Wildt SN
Paediatr Drugs; 2020 Aug; 22(4):433-444. PubMed ID: 32507958
[TBL] [Abstract][Full Text] [Related]
9. The bioavailability and maturing clearance of doxapram in preterm infants.
Flint RB; Simons SHP; Andriessen P; Liem KD; Degraeuwe PLJ; Reiss IKM; Ter Heine R; Engbers AGJ; Koch BCP; Groot R; Burger DM; Knibbe CAJ; Völler S;
Pediatr Res; 2021 Apr; 89(5):1268-1277. PubMed ID: 32698193
[TBL] [Abstract][Full Text] [Related]
10. Inter-individual variability in propofol pharmacokinetics in preterm and term neonates.
Allegaert K; Peeters MY; Verbesselt R; Tibboel D; Naulaers G; de Hoon JN; Knibbe CA
Br J Anaesth; 2007 Dec; 99(6):864-70. PubMed ID: 17965417
[TBL] [Abstract][Full Text] [Related]
11. Altered gentamicin pharmacokinetics in term neonates undergoing controlled hypothermia.
Bijleveld YA; de Haan TR; van der Lee HJ; Groenendaal F; Dijk PH; van Heijst A; de Jonge RC; Dijkman KP; van Straaten HL; Rijken M; Zonnenberg IA; Cools F; Zecic A; Nuytemans DH; van Kaam AH; Mathot RA;
Br J Clin Pharmacol; 2016 Jun; 81(6):1067-77. PubMed ID: 26763684
[TBL] [Abstract][Full Text] [Related]
12. A gentamicin pharmacokinetic population model and once-daily dosing algorithm for neonates.
DiCenzo R; Forrest A; Slish JC; Cole C; Guillet R
Pharmacotherapy; 2003 May; 23(5):585-91. PubMed ID: 12741432
[TBL] [Abstract][Full Text] [Related]
13. The effect of postnatal age on gentamicin pharmacokinetics in neonates.
Knight JA; Davis EM; Manouilov K; Hoie EB
Pharmacotherapy; 2003 Aug; 23(8):992-6. PubMed ID: 12921246
[TBL] [Abstract][Full Text] [Related]
14. Empirical gentamicin dosing based on serum creatinine levels in premature and term neonates.
Antolik TL; Cunningham KJ; Alabsi S; Reimer RA
Am J Health Syst Pharm; 2017 Apr; 74(7):466-472. PubMed ID: 28336756
[TBL] [Abstract][Full Text] [Related]
15. Population pharmacokinetics of gentamicin and dosing optimization for infants.
Medellín-Garibay SE; Rueda-Naharro A; Peña-Cabia S; García B; Romano-Moreno S; Barcia E
Antimicrob Agents Chemother; 2015 Jan; 59(1):482-9. PubMed ID: 25385111
[TBL] [Abstract][Full Text] [Related]
16. Time course of trough serum gentamicin concentrations in preterm and term neonates.
de Cos MA; Gómez-Ullate J; Gómez F; Armijo JA
Clin Pharmacokinet; 1992 Nov; 23(5):391-401. PubMed ID: 1478006
[TBL] [Abstract][Full Text] [Related]
17. [Pharmacokinetic and therapeutic monitoring of gentamicin serum concentration in neonates].
Kaminska E; Piekarczyk A; Prokopczyk J; Zimak J; Sosnowska K; Taljanski W
Med Wieku Rozwoj; 2001; 5(2):141-7. PubMed ID: 11679678
[TBL] [Abstract][Full Text] [Related]
18. Serum cystatin C is a major predictor of vancomycin clearance in a population pharmacokinetic analysis of patients with normal serum creatinine concentrations.
Chung JY; Jin SJ; Yoon JH; Song YG
J Korean Med Sci; 2013 Jan; 28(1):48-54. PubMed ID: 23341711
[TBL] [Abstract][Full Text] [Related]
19. Prediction of gentamicin concentrations in neonates and infants using a Bayesian pharmacokinetic model.
Rodvold KA; Gentry CA; Plank GS; Kraus DM; Nickel E; Gross JR
Dev Pharmacol Ther; 1993; 20(3-4):211-9. PubMed ID: 7828456
[TBL] [Abstract][Full Text] [Related]
20. Population pharmacokinetics of vancomycin and AUC-guided dosing in Chinese neonates and young infants.
Chen Y; Wu D; Dong M; Zhu Y; Lu J; Li X; Chen C; Li Z
Eur J Clin Pharmacol; 2018 Jul; 74(7):921-930. PubMed ID: 29602981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
